Bustar Pharmaceuticals (603858.SH) released its first quarter financial results, with a net profit attributable to shareholders of 307 million yuan, a year-on-year increase of 169.49%.

China Fortune Financial News APP news, BU Chang Pharmaceutical (603858.SH) disclosed the first quarter report of 2025, during the reporting period, the company achieved a revenue of 2.785 billion yuan, a year-on-year increase of 5.47%; the net profit attributable to the mother was 307 million yuan, a year-on-year increase of 169.49%; the non-net profit was 3 billion yuan, a year-on-year increase of 197.05%. Basic earnings per share were 0.2899 yuan.